A Win For FBRX
Thu, Oct 29, 2020 at 05:30 PM
FBRX (FBRX:NASDAQ) shot up at $36.38, a gain of 26.9%. On Wed 28 Oct 20, FBRX:NASDAQ touched a New 2-Week Low of $28.66. The stock got featured on our News Catalysts scanner on Thu 29 Oct 20 at 10:31 AM in the 'PUBLIC OFFERING' category. From Wed 14 Oct 20, the stock recorded 30.00% Up Days and 18.18% Green Days
About FBRX (FBRX:NASDAQ)
Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial in mid-2020.
Top 10 Gainers:
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 62.69%
- Polar Power, Inc. (POLA:NASDAQ), 58.8%
- Rekor Systems, Inc. (REKR:NASDAQ), 30.42%
- FBRX (FBRX:NASDAQ), 26.94%
- Pinterest, Inc. (PINS:NYSE), 26.92%
- Inphi Corporation (IPHI:NYSE), 26.7%
- IPHI (IPHI:NASDAQ), 26.7%
- RAVE Restaurant Group, Inc. (RAVE:NASDAQ), 25.47%
- Meta Financial Group, Inc. (CASH:NASDAQ), 25.4%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 22.47%